Vivos Therapeutics Inc is a medical technology company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
VVOS is expected to report earnings to rise 151.11% to -112 cents per share on March 28
Q4'23
Est.
$-1.13
Q1'25
Missed
by $0.04
Q4'24
Beat
by $0.77
Q3'24
Beat
by $0.25
Q3'23
Beat
by $1.25
The last earnings report on May 16 showed earnings per share of -44 cents, missing the estimate of -40 cents. With 98.85K shares outstanding, the current market capitalization sits at 6.43M.